ArticleJournal of racial and ethnic health disparities2025
Excellent Patient-Provider Communication May Mitigate Racial and Ethnic Disparities in Diabetes Care Management Among Cancer Survivors.
Article in Journal of racial and ethnic health disparities, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCancer survivors with diabetes require routine, high-quality care to prevent complications and support positive health outcomes. Racial and ethnic disparities in diabetes care may contribute to differences in disease management. This study examined disparities in diabetes management among cancer survivors and the role of patient-provider communication (PPC) in addressing these gaps.
methodsWe conducted a retrospective cross-sectional analysis using 2008-2021 Medical Expenditure Panel Survey data. The study population included diabetic cancer survivors who self-reported PPC quality and diabetes care utilization. The primary exposure was excellent vs. less than excellent PPC, and outcomes included adherence to diabetes management guidelines, defined as receiving ≥ 2 HbA1c tests, an annual foot exam, and an annual eye exam.
resultsStratified analyses revealed significant variation in the association between excellent PPC and receipt of guideline-concordant care. Among Hispanic patients, excellent PPC was associated with higher odds of receiving ≥ 2 HbA1c tests (OR: 2.62, 95% CI: 2.25-2.70), foot exams (OR: 1.65, 95% CI: 1.59-1.70), and eye exams (OR: 1.12, 95% CI: 1.08-1.16). Asian patients with excellent PPC also had higher odds of ≥ 2 HbA1c tests (OR: 4.97, 95% CI: 4.59-5.37) and an annual foot exam (OR: 1.60, 95% CI: 1.50-1.70). In contrast, Non-Hispanic Black patients with excellent PPC were significantly less likely to receive all three diabetes screenings compared to those with not excellent PPC. Among Non-Hispanic White survivors, excellent PPC was associated with modestly higher odds of foot and eye exams.
conclusionAmong cancer survivors with diabetes, the impact of excellent PPC on diabetes management varied by race and ethnicity. While excellent PPC was associated with improved screening among Hispanic and Asian survivors, it was associated with lower odds of diabetes management among Non-Hispanic Black survivors. These findings suggest additional systemic factors may contribute to the inverse association observed for Black cancer survivors.
Indexed as
Identifiers
41239174What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.